课题基金 / 基金详情

A LINE-1 Retrotransposition-Deficient Mouse Genome

A LINE-1 Retrotransposition-Deficient Mouse Genome
LINE-1 逆转录转座缺陷小鼠基因组
批准号:
9925240
负责人:
ALEX BORTVIN
金额:
$21.47万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-02 至 2022-04-30

项目摘要

项目成果

ALEX BORTVIN的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 转座因子(TE)是离散的移动的DNA序列,其完整的和突变的拷贝构成一个完整的DNA序列。 宿主基因组的很大一部分。在过去的十年中,许多研究表明TE参与了进化 基因组和基因表达网络。然而,TE是否有助于发育或疾病是一个问题。 开放的关键问题的答案,这可能会扩大,甚至从根本上改变我们对遗传的看法, 人类健康和病理学的基础。对人类健康特别感兴趣的是一种长时间散布的 元素1(LINE-1或L1)。例如,超过100种单基因人类疾病是由L1插入引起的。 有趣的是,最近的研究表明L1反转录转座在正常发育(胚胎发生,卵子发生, 神经发生)、衰老和疾病(自身免疫性疾病、癌症)。然而,尽管有许多相关的 然而,迄今为止,没有一项研究确定L1逆转录在这些过程中的致病作用。主 研究内源性L1的挑战在于哺乳动物基因组中存在大量全长完整的L1。 转录或转录后水平的TE活性的实验性降低并不提供 在复杂组织中特异、稳定和长期的L1抑制。这份R21提案旨在迈出第一步, 缩小我们在理解L1对发育和疾病的作用方面的差距。我们提出 一种逐步和系统地扩增小鼠基因组中全长L1元件的实验策略 胚胎干细胞(ESC)模型。我们将监测和量化L1诱变的程度, 最终确定候选ESC克隆,我们将随后在体内测试其发育潜力。的 拟议中的研究将为今后对L1在发展中的作用进行严格测试提供基础, 疾病 相关性 过去十年的研究表明,移动的元件反转录转座子L1与健康发育和疾病有关。 如果这是真的,这一论点将从根本上扩大我们对人类健康遗传基础的理解, 病理我们建议通过系统地灭活L1基因组中的元件来验证这一假设。 小鼠胚胎干细胞和表征缺乏活性L1的基因组的发育潜力 元素
英文摘要
Project Summary Transposable elements (TEs) are discrete mobile DNA sequences whose intact and mutated copies constitute a substantial fraction of host genomes. Over the past decade, numerous studies implicated TEs in the evolution of genomes and gene expression networks. However, whether TEs contribute to development or disease is an open crucial question answering which might expand and even radically change our views on the genetic foundations of human health and pathology. Of particular interest to human health is a Long Interspersed Element 1 (LINE-1 or L1). For example, over a hundred single-gene human diseases arose from L1 insertions. Intriguingly, recent studies implicated L1 retrotransposition in normal development (embryogenesis, oogenesis, neurogenesis), aging and disease (autoimmune disorders, cancers). However, despite a multitude of correlative studies, none have established a causative role of L1 retrotransposition in these processes to date. The primary challenge of studying endogenous L1s lies in the large numbers of full-length intact L1s in mammalian genomes. Experimental reduction of TE activity at the transcriptional or post-transcriptional levels does not provide specific, stable and long-term L1 repression in complex tissues. This R21 proposal aims to make the first step toward closing this gap in our understanding of the contribution of L1 to development and disease. We propose an experimental strategy to gradually and systematically inactivate full-length L1 elements in the mouse genome using the embryonic stem cell (ESC) model. We will monitor and quantify the extent of L1 mutagenesis and ultimately identify candidate ESC clones whose developmental potential we will subsequently test in vivo. The proposed research will provide the foundation for future rigorous tests for the role of L1s in development and disease. Relevance Studies over the past decade implicated mobile element retrotransposon L1 in healthy development and disease. If true, this contention will radically expand our understanding of the genetic foundations of human health and pathology. We propose to test this hypothesis by systematically inactivating L1 elements in the genome of mouse embryonic stem cells and characterizing the developmental potential of genomes lacking active L1 elements.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pgen.1010797
发表时间: 2023-06
期刊: PLoS genetics
影响因子: 4.5
作者: []
通讯作者:
A Universal DNA Hemimethylation Probe
An RNA:DNA intermediate of LINE-1 retrotransposition - a novel trigger of cytotoxicity
IDENTIFYING MAELSTROM COMPLEXES
  • 批准号:
    8365884
  • 项目类别:
  • 资助金额:
    $0.85万
  • 财政年份:
    2011
  • 负责人:
    ALEX BORTVIN
  • 依托单位:
海外基金